Item 8.01 Other Events.
On December 20, 2022, Satsuma Pharmaceuticals, Inc. (the "Company") issued a
press release providing an update on its STS101 development program as well as a
general corporate update. The full text of the press release is furnished as
Exhibit 99.1 hereto. In addition, the Company made available on its website a
presentation discussing the updated development program. A copy of the press
release and the presentation materials are attached hereto as Exhibits 99.1 and
99.2, respectively, and are incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press Release dated December 20, 2022
99.2 Company presentation dated December 20, 2022
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
SATSUMA PHARMACEUTICALS, INC. 
